License Agreements in the SPACs, Investment, & Acquisition Companies Industry

122 Contracts & Agreements

Browse by Company

AB Private Credit Investors Corp (1 contract)
Aesther Healthcare Acquisition Corp. (36)
ALTABA INC. (2)
AltEnergy Acquisition Corp (1)
AMCI Acquisition Corp. II (3)
Apollo Acquisition Corp (1)
Avista Public Acquisition Corp. II (2)
Bio-En Holdings Corp. (1)
Bull Horn Holdings Corp. (1)
Burgundy Technology Acquisition Corp (1)
Caesars Acquisition Co (6)
China Nutrifruit Group LTD (1)
COLONY RESORTS LVH ACQUISITIONS LLC (1)
GAINSCO INC (1)
GAMERICA HOLDINGS & ACQUISITIONS CORP. (1)
GigCapital5, Inc. (1)
Golden Arrow Merger Corp. (1)
Golden Star Enterprises Ltd. (1)
Helix Acquisition Corp (3)
Intellicell Biosciences, Inc. (7)
iStar Acquisition Corp. (1)
J.W. Childs Acquisition I Corp. (1)
JATT Acquisition Corp (2)
JAVELIN MORTGAGE INVESTMENT CORP. (1)
Larkspur Health Acquisition Corp. (1)
LEAP WIRELESS INTERNATIONAL INC (1)
Learn SPAC HoldCo, Inc. (2)
LMF Acquisition Opportunities Inc (10)
Monterey Capital Acquisition Corp (1)
MTGE Investment Corp. (1)
Murphy Canyon Acquisition Corp. (1)
Nubia Brand International Corp. (2)
Pathfinder Acquisition Corp (2)
Patricia Acquisition Corp. (1)
Patriot Coal CORP (1)
Priveterra Acquisition Corp. (5)
Silver Spike Investment Corp. (2)
SMSA Treemont Acquisition Corp (1)
STIRLING ACQUISITION CORP (1)
STRATEGIC ACQUISITIONS INC (1)
TenX Keane Acquisition (3)
TERCICA INC (2)
TradeUP Acquisition Corp. (1)
TRIAN ACQUISITION I CORP. (1)
Venetian-1 Acquisition Corp. (2)
Vickers Vantage Corp. I (1)
Viveon Health Acquisition Corp. (2)

Recent Contracts

License Agreement, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Bala Therapeutics, Inc (Venetian-1 Acquisition Corp., Filed With SEC on November 7, 2024)
License Agreement, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Eil Therapeutics, Inc (Venetian-1 Acquisition Corp., Filed With SEC on November 7, 2024)
Rest of World License Term Sheet, dated October 8, 2024, between Oramed Pharmaceuticals, Inc., Scilex Holding Company and the other parties signatories thereto (Vickers Vantage Corp. I, Filed With SEC on October 8, 2024)
License Agreement, dated October 1, 2024, between the Company and the Adviser (Silver Spike Investment Corp., Filed With SEC on October 7, 2024)
License Agreement, dated August 7, 2024, between AstraZeneca AB (PUBL) and Conduit Pharmaceuticals Inc (Murphy Canyon Acquisition Corp., Filed With SEC on September 13, 2024)
Supply and License Agreement, dated as of August 1, 2021, by and between Bolt Threads, Inc. and Vegamour, Inc (Golden Arrow Merger Corp., Filed With SEC on August 19, 2024)
Shinyoung Know-How License Agreement (AltEnergy Acquisition Corp, Filed With SEC on August 12, 2024)
Amendment No. 1 to the License and Distribution Agreement, dated December 29, 2023, by and between the Company and Nuwellis, Inc (LMF Acquisition Opportunities Inc, Filed With SEC on April 16, 2024)
Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on April 15, 2024)
Data Use and License Agreement, dated April 3, 2024, by and between QT Imaging Center and QT Imaging Holdings, Inc (GigCapital5, Inc., Filed With SEC on April 8, 2024)
Third Amendment to License and Supply Agreement, dated April 24, 2023, by and between Daewoong Pharmaceutical Co (Priveterra Acquisition Corp., Filed With SEC on April 2, 2024)
Second Amendment to the License and Supply Agreement, dated as of January 8, 2023, by and between AEON Biopharma, Inc. and Daewoong Pharmaceutical Co., Ltd (Priveterra Acquisition Corp., Filed With SEC on April 2, 2024)
Fourth Amendment to License and Supply Agreement, dated March 19, 2024, by and between AEON Biopharma, Inc. and Daewoong Pharmaceutical Co., LTD (Priveterra Acquisition Corp., Filed With SEC on March 19, 2024)
License and Services Agreement, dated as of February 20, 2024, by and between Magna New Mobility USA, Inc. and Serve Operating Co (Patricia Acquisition Corp., Filed With SEC on February 23, 2024)
Supply and License Agreement, dated February 2, 2024, by and between Global Graphene Group, Inc., Angstron Materials, Inc., and Honeycomb Battery Company (Nubia Brand International Corp., Filed With SEC on February 8, 2024)
Amended and Restated Patent and Know-How License Agreement, dated as of October 25, 2021, by and between the Procter & Gamble Company and AeroFlexx, LLC (Learn SPAC HoldCo, Inc., Filed With SEC on January 26, 2024)
Patent and Know How License Agreement, dated February 15, 2018, between Air Assist LLC and The Procter & Gamble Company (Learn SPAC HoldCo, Inc., Filed With SEC on January 26, 2024)
Leave and License Agreement, dated September 31, 2020, by and between Sree Ramulu Raju and ConnectM Technology Solutions Private Limited (Monterey Capital Acquisition Corp, Filed With SEC on December 21, 2023)
Amendment No. 2 to Amended and Restated License, Development and Commercialization Agreement, dated as of August 31, 2021, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (TenX Keane Acquisition, Filed With SEC on November 13, 2023)
Amendment No. 1 to Amended and Restated License, Development and Commercialization Agreement, dated as of August 9, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (TenX Keane Acquisition, Filed With SEC on November 13, 2023)
Amended and Restated License, Development and Commercialization Agreement, dated as of February 26, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A (TenX Keane Acquisition, Filed With SEC on November 13, 2023)
License Agreement, dated as of August 16, 2023, by and between Coeptis Therapeutics Holdings, Inc. and Deverra Therapeutics, Inc (Bull Horn Holdings Corp., Filed With SEC on August 22, 2023)
License, Development and Commercialization Agreement between ZB17 LLCand Eli Lilly and Company, dated April 26, 2023 (JATT Acquisition Corp, Filed With SEC on August 11, 2023)
Novation, Amended and Restatement of License Agreement, dated June 1, 2023, between MoonLake Immunotherapeutics AG, Research Corporation Technologies, Inc. and Merck KGaA (Helix Acquisition Corp, Filed With SEC on August 10, 2023)
Form of Supply and License Agreement (Nubia Brand International Corp., Filed With SEC on February 17, 2023)
Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Third Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Second Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31, 2021 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
First Amendment to Exclusive License Agreement (BROWN ID 3039) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21, 2021 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Exclusive License Agreement BROWN ID 3039 Bi Specific Antibody Anti-CTLA4 between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July 31,... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Sixth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Fifth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Fourth Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Third Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25,... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Second Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 31,... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
First Amendment to Exclusive License Agreement (BROWN ID 2465, 2576, 2587) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 21,... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Exclusive License Agreement BROWN ID 2465, 2576, 2587 (FRG) Antibody between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated July 31, 2020 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Fifth Amendment to Exclusive License Agreement (RIH #154) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated August 26, 2022 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Fourth Amendment to Exclusive License Agreement RIH #154 PfsLSP-1 a Vaccine for Falciparum Malaria RIH #305 Antibodies to Pfgarp Kill Plasmodium Falciparum Malaria Parasites and... (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)
Third Amendment to Exclusive License Agreement (RIH #154) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a Ocean Biomedical Holdings, Inc.) dated March 25, 2022 (Aesther Healthcare Acquisition Corp., Filed With SEC on February 15, 2023)